Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19

Patients with COVID-19 are at higher risk of thrombosis due to the inflammatory nature of their disease. A higher-intensity approach to pharmacologic thromboprophylaxis may be warranted. The objective of this retrospective cohort study was to determine if a patient specific, targeted-intensity pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Farrar, Julie E., Trujillo, Toby C., Mueller, Scott W., Beltran, Lyra, Nguyen, Cecilia, Hassell, Kathryn, Kiser, Tyree H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375286/
https://www.ncbi.nlm.nih.gov/pubmed/34410561
http://dx.doi.org/10.1007/s11239-021-02552-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375286/
https://www.ncbi.nlm.nih.gov/pubmed/34410561
http://dx.doi.org/10.1007/s11239-021-02552-x

Ejemplares similares